sumatriptan has been researched along with pentylenetetrazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jand, A; Palizvan, MR | 1 |
| Aghamollaii, V; Ahmadi, M; Amiri, S; Dehpour, AR; Ghasemi, K; Gooshe, M; Rohani, MM; Tafakhori, A | 1 |
| Abdollahi, A; Alotaibi, G; Dehpour, AR; Ghazi-Khansari, M; Imran Khan, M; Mumtaz, F; Rashki, A; Shadboorestan, A | 1 |
| Kilinc, E; Kılınc, YB; Torun, IE | 1 |
| Amanlou, A; Dehpour, AR; Ejtemaei-Mehr, S; Eslami, F; Ghasemi, M; Rahimi, N; Rashidian, A; Shayan, M; Solaimanian, S | 1 |
5 other study(ies) available for sumatriptan and pentylenetetrazole
| Article | Year |
|---|---|
Sumatriptan, an Antimigraine Drug, Inhibits Pentylenetetrazol-induced Seizures in NMRI Mice.
Topics: Animals; Anticonvulsants; Male; Mice; Migraine Disorders; Pentylenetetrazole; Seizures; Sumatriptan; Vasoconstrictor Agents | 2017 |
Biphasic effect of sumatriptan on PTZ-induced seizures in mice: Modulation by 5-HT1B/D receptors and NOS/NO pathway.
Topics: Animals; Anticonvulsants; Convulsants; Dose-Response Relationship, Drug; Male; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pentylenetetrazole; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Seizures; Signal Transduction; Sumatriptan | 2018 |
Neuroprotective effect of sumatriptan in pentylenetetrazole-induced seizure is mediated through N-methyl-D-aspartate/nitric oxide and cAMP response element-binding protein signaling pathway.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Mice; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide; Pentylenetetrazole; Seizures; Signal Transduction; Sumatriptan | 2022 |
Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats.
Topics: Animals; Anticonvulsants; Epilepsy; Fluoxetine; Humans; Interleukin-6; Male; Neuroinflammatory Diseases; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Serotonin; Sumatriptan; Tumor Necrosis Factor-alpha | 2022 |
Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or K
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; bcl-2-Associated X Protein; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Glyburide; Mice; Models, Theoretical; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pentylenetetrazole; Piperidines; Potassium Channel Blockers; Potassium Channels; Pyridines; Receptors, Opioid; Seizures; Stroke; Sumatriptan; Tumor Necrosis Factor-alpha | 2022 |